DermaSensor Featured in The Washington Post! We’re proud to see one of our valued customers, Dr. Mitchell A Kline MD of NewYork-Presbyterian Hospital Weill Cornell Medicine Center, featured in a recent Washington Post article on the future of AI in skin cancer detection. 🩺 Dr. Kline highlights how handheld tools like DermaSensor can expand access skin cancer risk detection, especially in underserved communities. “The real potential value of the tools is for clinicians whose ability to diagnose is less reliable and who don’t have access to other diagnostic devices,” Dr. Kline shared. We’re excited to be part of the future of skin cancer detection—where AI can enhance the quality of healthcare delivery. Read more: https://lnkd.in/eP6EWBBe #SkinCancerAwareness #AIinHealthcare #EarlyDetection #PrimaryCare #HealthTech #MedicalDevice #MedTech #DermatologyInnovation #Healthcare
DermaSensor, Inc.
Medical Equipment Manufacturing
Miami, Florida 4,694 followers
The Future of Skin Cancer Detection — Now FDA Cleared.
About us
Now cleared by the U.S. Food and Drug Administration (FDA), DermaSensor equips physicians with immediate, accurate, and objective results that improve skin cancer detection through data-driven breakthrough technologies.
- Website
-
www.dermasensor.com
External link for DermaSensor, Inc.
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Miami, Florida
- Type
- Privately Held
- Founded
- 2009
- Specialties
- Medical Equipment, Skin Cancer, Skin Health, Innovation, Innovative Technology, PCP, Medical Device, and Skin Cancer Evaluation
Locations
-
Primary
Get directions
Brickell Ave
Miami, Florida, US
-
Get directions
Collingwood, Vic, AU
Employees at DermaSensor, Inc.
-
Andrew Livingston
AI Innovation & Acceleration | UX | Board Advisor | Digital Health Pioneer | Former Chief Innovation Officer, Harrow (NASDAQ: HROW) | Co-Founder &…
-
Ivan Delevic
-
S. Ryan Freiden
COO @ DermaSensor | Innovative Technology Executive | Lean Growth Master | Early-Stage Investor | Oxford Comma Supporter
-
Cody Simmons
CEO, DermaSensor Inc | HealthTech | Entrepreneur
Updates
-
Exciting News! Our CEO, Cody Simmons, was recently featured in an insightful article by The Healthcare Technology Report! In the interview, he dives into the journey behind DermaSensor, Inc. and how we’re building tools that fit the hands that need them most— primary care providers (PCPs) who are considered the first line of defense in identifying and managing health problems. It’s all about making healthcare more accessible, efficient, and impactful. 👉 Read full article below Like, share, and follow us for more insights into DermaSensor: the first FDA Cleared handheld skin cancer detection device. #HealthTech #MedTech #SkinCancer #Physician #Healthcare #AIinHealthCare #SkinCancerAwareness #PrimaryCare #MedicalInnovation #FounderStory #EquityInCare
The Bioengineer Behind the First Handheld Skin Cancer Detection Tool Cody Simmons believes life-saving tech shouldn’t be locked in a specialist’s office. That’s what drew him to DermaSensor, Inc., where he’s spent the past eight years as CEO turning a microwave-sized device into the first FDA-cleared, handheld skin cancer detection tool for primary care physicians. When Simmons joined DermaSensor in 2016, he was a 20-something bioengineer with a Stanford master’s, four years at Genentech, and a burning interest in healthtech. What he didn’t have was a product ready for market–or anything close. The company’s core technology had potential, but the device was bulky, expensive, and unproven. Still, Simmons saw something others didn’t: a path to democratize early skin cancer detection for millions of Americans who never see a dermatologist. He helped miniaturize the hardware, oversaw 13 clinical studies, and navigated an FDA process that had stumped dozens of other startups. While competitors chased photo-based solutions with high failure rates and limited usability, Simmons’ team followed the science–betting on optical spectroscopy and a product that gave physicians an answer every time, regardless of skin type. The payoff came in 2024: FDA clearance for the first device to provide automated skin cancer risk assessments for frontline providers. For the first time, a family doctor in rural Iowa–or a busy OB-GYN in Miami–could quickly and non-invasively assess a suspicious mole with a simple point-and-click tool. The launch was the culmination of a 15-year R&D journey and $25 million in investment. But for Simmons, it was also validation for taking the harder path–resisting calls to focus on dermatologists, holding firm on affordability and ease of use, and listening closely to physicians who wanted actionable data, not complexity. He added a one-to-ten confidence scale, changed output language to avoid panic, and tested abroad to get real-world feedback before U.S. launch. Now, with growing interest from health systems and practitioners alike, DermaSensor is proving that health equity, access, and innovation don’t have to be at odds. And Simmons is proving what happens when a founder refuses to cut corners–and instead builds something that actually fits the hands that need it.
-
-
Thank you for visiting DermaSensor at Tech Hub at the American College of Physicians Internal Medicine Meeting 2025 in New Orleans! At DermaSensor, we recognize a significant gap in the effective assessment of skin cancer risk, a critical concern for both patients and for clinicians who are not experts in dermatology. Our mission is to bridge this gap by delivering objective, reliable solutions that empower physicians to non-invasively test for skin cancer risk at the point of care. The significant interest and positive feedback around our device at the Internal Medicine Meeting 2025 was remarkable. It's clear that we are truly helping internal medicine physicians bridge this gap in skin cancer detection. Join the DermaSensor Revolution, like, share, and follow us. To learn more about our technology, pricing, and reimbursement options. Visit: https://lnkd.in/evaMxZHm #InternalMedicine2025 #MedicalInnovation #NewOrleans #Conference #SkinCancer #FamilyPhysician #Lousiana #MeetTheTeam #LiveDemo #Healthcare #MedicalDevice #IM2025 #InternalMedicine
-
-
DermaSensor will be at the ACP Internal Medicine Meeting 2025 this week! American College of Physicians Stop by Tech Hub #2113 for a live demo and learn how to implement DermaSensor into your practice. Meet our team: •Ruth Stachura, MBA, National Sales Director •Jacqueline Barberena, Senior Marketing Director •Dr. Kiran Chatha, Associate Director of Clinical and Medical Affairs #MedicalInnovation #NewOrleans #Conference #SkinCancer #FamilyPhysician #Lousiana #MeetTheTeam #LiveDemo #Healthcare #MedicalDevice #IM2025 #InternalMedicine
-
-
Exciting Moment at eMerge Americas: DermaSensor Shines in Miami! DermaSensor was selected as one of the top 25 startups in the late-stage startup competition at eMerge Americas in Miami last week! CEO and Co-Founder Cody Simmons delivered an inspiring pitch that highlighted: •Critical skin cancer statistics •Personal motivation behind DermaSensor's mission •Innovative approach to skin cancer detection Cody's journey was deeply personal, inspired by his mother's skin cancer diagnosis, and developed in collaboration with Dr. Maurice R. Ferre M.D. Click on the video below for a snippet! Like, share, and follow us for the latest updates. #Miami #SkinCancer #MedicalDevice #MedTech #HealthTech #Presentation #Healthcare #Physician #SkinCancerAwareness
-
April is National Cancer Control Month- This month-long observance emphasizes the importance of cancer prevention and early detection, including skin cancer. Patients: Schedule your DermaSensor assessment today and take a proactive step towards protecting your skin! Physicians: Summer is around the corner - add the DermaSensor device into your practice for a 30-second skin cancer risk assessment for your patients! Our cutting-edge technology provides: •Immediate, objective skin cancer risk results •Non-invasive assessment •Proprietary, FDA Cleared algorithm Did you know? When caught early, skin cancer has a 99% survival rate. Protect your most important asset - YOUR HEALTH! Reference: https://lnkd.in/g2mrX54S #NationalCancerControlMonth #EarlySkinCancerDetection #MedicalDevice #HealthAwareness #SkinCancerScreening #Patient #Physician #Healthcare #Awareness #SkinCancer
-
-
The Future is Here – and DermaSensor is Leading the Way! The global dermatology market is expected to nearly double in value over the next decade, driven by AI-powered diagnostics, minimally invasive treatments, and expanding patient awareness. 💡 Key Market Trends: •AI-driven diagnostics for immediate, objective skin assessments •Rising demand for aesthetic and preventive dermatology •Expanding access to innovative skin health solutions worldwide As part of this growing industry, DermaSensor is proud to be recognized among top companies shaping the future of skin health. Stay ahead of the curve—follow us for more updates! #DermatologyInnovation #AIinHealthcare #SkinCancerAwareness #MedTech #SkinHealth #SkinCancer #GlobalTrends #Healthcare
𝗔 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗣𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲 𝗳𝗼𝗿 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗟𝗲𝗮𝗱𝗲𝗿𝘀 𝗶𝗻 𝗗𝗲𝗿𝗺𝗮𝘁𝗼𝗹𝗼𝗴𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 The global dermatology market is undergoing a rapid transformation, with its valuation set to grow from $1.41 billion in 2024 to an estimated $2.75 billion by 2034. This evolution is being driven by cutting-edge innovations, increasing demand for aesthetic solutions, and rising awareness of skin health. For business managers and consultants, this is an opportune moment to explore investment and expansion strategies in a thriving sector. Source: https://lnkd.in/dQ4vvDMv 𝗞𝗲𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗧𝗿𝗲𝗻𝗱𝘀 𝘁𝗼 𝗪𝗮𝘁𝗰𝗵 ✅ AI-Powered Dermatology: Artificial intelligence is revolutionizing diagnostics and treatment personalization, leading to faster and more accurate outcomes. ✅ Boom in Aesthetic Dermatology: The demand for minimally invasive procedures and premium skincare products is surging, fueled by social media and consumer awareness. ✅ Expansion in Emerging Markets: With Asia-Pacific leading the charge and North America experiencing unprecedented growth, regional strategies must be redefined. ✅ Strategic M&A Activity: Industry giants like Gilead Sciences, LEO Pharma, and Almirall are engaging in acquisitions and partnerships to expand market presence. 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀 𝗳𝗼𝗿 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗚𝗿𝗼𝘄𝘁𝗵 📌 Tech-Enabled Solutions: Companies that integrate AI, laser therapy, and nanotechnology into their services are set to gain a competitive edge. 📌 Scaling Up Dermatology Clinics: Expanding specialized clinics in high-demand regions can address accessibility gaps and drive revenue. 📌 Product Innovation & Brand Differentiation: Developing personalized skincare lines and investing in R&D can unlock new revenue streams. 𝗧𝗼𝗽 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗗𝗲𝗿𝗺𝗮𝘁𝗼𝗹𝗼𝗴𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 Almirall, Inc. Bausch Health Companies Inc. Clinikally (YC S22) Cutera DermaSensor, Inc. Galderma Gilead Sciences, Inc. Glenmark Pharmaceuticals Integral Lifesciences Johnson & Johnson LEO Pharma Novartis Pfizer Plum Roivant Sciences Tarsus Pharmaceuticals, Inc. 𝗙𝗶𝗻𝗮𝗹 𝗧𝗵𝗼𝘂𝗴𝗵𝘁 The dermatology sector is no longer just about skincare—it’s a dynamic, high-growth industry offering strategic opportunities for businesses looking to expand. Whether through M&As, technology adoption, or regional expansion. If you have any queries, or want to talk with healthcare experts, connect @ https://lnkd.in/dAfduwMg
-
📢 Join Us at #AC25! Stop by Booth #1111 in The Hub during exhibit hall hours to learn more about DermaSensor! Say hi to our Area Sales Director, Jordan Whittle, and get a quick demo of the DermaSensor device, providing skin cancer risk results in under 30 seconds! Don’t miss this opportunity to see how DermaSensor is transforming skin cancer assessment. Like, share, and follow us! #AC25 #SkinCancerDetection #MedicalInnovation #HealthcareTech #VisitUs
-
-
🩺 Celebrating National Physicians Week: Honoring the Healers Who Make a Difference! At DermaSensor, we're proud to recognize the incredible dedication, expertise, and compassion of physicians who transform lives every single day. Your commitment to patient care and medical innovation continues to inspire us. To all the amazing doctors out there: THANK YOU for your unwavering commitment to health and healing. #NationalPhysiciansWeek #HealthcareProfessionals #MedicalInnovation #PhysicianAppreciation #ProfessionalRecognition #HealthTech #TogetherWeThriveIn2025
-
-
DermaSensor is a Proud Partner of the American Academy of Family Physicians! Join us at the AAFP Residency Leadership Summit in Kansas City, MO from March 25-26,2025! Stop by Table 12 for a LIVE demo and learn more on how to integrate DermaSensor into your clinical workflow! Experience firsthand how this non-invasive, cutting-edge technology can enhance your clinical decision-making referrals. #AAFP #ResidencyLeadershipSummit #SkinCancerDetection #PrimaryCare #MedicalInnovation #SkinCancer #MedTech #Healthcare
-